Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men

Journal of Urology

Volumn 166, Issue 4, 2001, Pages 1328-1332

  Bissonette, Eric A ^b   Fulmer, Brant R ^b   Petroni, Gina R ^b   Moul, Judd W ^b   Theodorescu, Dan ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b Box 422 ^*

Author keywords

Prostate; Prostate specific antigen; Prostatectomy; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; CORRELATION FUNCTION; GROWTH RATE; HISTOPATHOLOGY; HUMAN; KINETICS; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; RACE DIFFERENCE; RETROSPECTIVE STUDY; SCORING SYSTEM; TUMOR GROWTH; VELOCITY;

EID: 0034831342     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(05)65762-x     Document Type: Article

References (32)

1. Prostate cancer screening and management
2. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting
3. Surgical control of clinically localized prostate carcinoma is equivalent in African-American and white males
4. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men
5. Survival in blacks and whites after treatment for localized prostate cancer
6. Evaluation of changes in PSA in the management of men with prostate cancer
7. Racial differences in a prostate cancer screening study
8. Observations on the doubling time of prostate cancer. The use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume
9. Natural history of progression after PSA elevation following radical prostatectomy
10. Recurrence patterns after radical retropubic prostatectomy: Clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen
11. Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer
12. Histologic grading of prostate cancer: A perspective
13. TNM classification of malignant tumors, fifth edition (1997)
14. Analysis of longitudinal data: Random coefficient regression modelling
15. Clinical observations on the doubling time of prostate cancer
16. Patient evaluation if prostate-specific antigen becomes elevated following radical prostatectomy or radiation therapy
17. Prostate specific antigen doubling time and disease relapse after radiotherapy for prostate cancer
18. Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer
19. A comparison of prostate knowledge of African-American and Caucasian men: Changes from prescreening baseline to postintervention
20. Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status
21. Radical prostatectomy: Lower rates among African-American men
22. Perceived benefits: A predictor of participation in prostate cancer screening
23. Predictors of participation in prostate cancer screening at worksites
24. The impact of prostate cancer knowledge on cancer screening
25. Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients
26. Epidemiology of high grade prostatic intraepithelial neoplasia
27. Age and racial distribution of prostatic intraepithelial neoplasia
28. Staging and reporting of prostate cancer - Sampling of the radical prostatectomy specimen
29. Serum testosterone levels in African-American and white men undergoing prostate biopsy
30. Serum testosterone levels in healthy young black and white men
31. Racial differences and prognostic significance of tumor location in radical prostatectomy specimens